MyShare
ALLO.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
| symbol | last | change | %chng | name | mcap | sector | wiki | |
|---|---|---|---|---|---|---|---|---|
ALLO | US | Allogene Therapeutics Inc | 1.142B | Healthcare |
Market global news for ALLO (US) Allogene Therapeutics
Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
| Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology tmcnet - 20:30 Wed 1 - ALLO - link story | |
| Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology yahoo - 20:30 Wed 1 - ALLO - link story | |
| Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology streetinsider - 20:15 Wed 1 - ALLO - link story | |
| Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology streetinsider - 20:15 Wed 1 - ALLO - link story | |
| Stock Market | FinancialContent Business Page financialcontent - 20:15 Wed 1 - ALLO - link story | |
| Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T™ Target for Small Cell Lung Cancer streetinsider - 17:00 Wed 25 - ALLO - link story | |
| Allogene Therapeutics (ALLO) Announces Publication Supporting DLL3 as a Potential AlloCAR T Target streetinsider - 14:15 Wed 25 - ALLO - link story | |
| Stock Market | FinancialContent Business Page financialcontent - 13:45 Wed 25 - ALLO - link story | |
| Why Allogene Therapeutics Shares Are Seeing Blue Skies Today businessinsider - 18:00 Tue 24 - ALLO - link story | |
| Allogene Therapeutics Shares Up 13% on Publication of ALLO-715 Trial Data marketwatch - 17:15 Tue 24 - ALLO - link story | |
| Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1 UNIVERSAL Study of ALLO-715 for the Treatment of Relapsed/Refractory Multiple Myeloma wallstreet-online de - 16:45 Tue 24 - ALLO - link story | |
| Allogene Therapeutics (ALLO) Announces Publication of Data from its Phase 1 UNIVERSAL Study of ALLO-715 streetinsider - 15:45 Tue 24 - ALLO - link story | |
| Moore Kuehn, PLLC Encourages Investors of Allogene globenewswire - 04:15 Mon 23 - ALLO - link story | |
| Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences tmcnet - 00:00 Wed 18 - ALLO - link story | |
| Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences yahoo - 21:45 Tue 17 - ALLO - link story | |
| Acquisition of Neogene Therapeutics completed pharmiweb - 12:45 Tue 17 - ALLO - link story | |
| Moore Kuehn, PLLC Encourages Investors of Allogene Therapeutics, Inc. to Contact Law Firm prnewswire - 18:30 Thu 5 - ALLO - link story | |
| Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development tmcnet - 13:30 Tue 3 - ALLO - link story |